Odds ratio analysis in women with endometrial cancer

Przeglad Menopauzalny

Volumn 15, Issue 1, 2016, Pages 12-19

  Plagens Rotman, Katarzyna ^a   Żak, Ewa ^a   Piȩta, Beata ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Endometrial cancer; Risk factors; The odds ratio of developing the disease

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; DAIRY PRODUCT; ENDOMETRIUM CANCER; FEMALE; FOOD INTAKE; HUMAN; LAMB; LIFESTYLE; MAJOR CLINICAL STUDY; ODDS RATIO; PHYSICAL ACTIVITY; PORK; PROPHYLAXIS; RED MEAT; RISK FACTOR; VEAL; VEGETABLE; WHEAT;

EID: 84962446709     PISSN: 16438876     EISSN: 22990038     Source Type: Journal    
DOI: 10.5114/pm.2016.58767     Document Type: Article

References (51)

1. Grosman-Dziewiszek P, Dziegiel P, Zabel M. Disturbance of gene expression in endometrial cancer as therapy aim. Ginekol Pol 2011;82:276-280.
2. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. International Agency for Research on Cancer; Lyon 2010.
3. Żyła MM, Kostrzewa M, Litwińska E, et al. The role of angiogenic factors in endometrial cancer. Prz Menopauzalny 2014;13:122-126.
4. Markowska J, Mądry R. Zarys ginekologii onkologicznej. [Outline of gynecological oncology]. Termedia, Poznań 2012.
5. Doll A, Abal M, Rigau M, et al. Novel molecular profiles of endometrial cancer - new light through old windows. J Steroid Biochem Mol Biol 2008;108:221-229.
6. Pawłowicz PS, Ajdacka U. The role of laparoscopy in the surgical treatment of endometrial cancer. Videosurgery Miniinv 2015;10:44-48.
7. Zając A, Stachowiak G, Stetkiewicz T, Wilczyński JR. TP53 gene and p53 protein vs. endometrial carcinoma. Prz Menopauzalny 2013;3:228-230.
8. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005;366:491-505.
9. Baltaziak M, Kańczuga-Koda L, Rutkowski R, et al. Komunikacja miȩdzykomórkowa z udziałem połączeń typu gap w karcinogenezie błony śluzowej trzonu macicy. [Gap junction intercellular communication in carcinogenesis of endometrial cancer]. Ginekol Pol 2011;82:520-524.
10. Gottwald L, Kubiak R, Pasz-Walczak G, et al. Znaczenie ekspresji receptorów progesteronowych i estrogenowych ocenianej metodą mikromacierzy tkankowych dla rokowania u chorych z gruczolakorakiem endometrioidalnym endometrium. [The value of progesterone and estrogen receptors expression in tissue microarray method in prognosis of patients with endometrioid endometrial Cancer]. Ginekol Pol 2013;84:95-101
11. Friedenreich C, Cust A, Lahmann PH, et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control 2007;18:399-413.
12. Schouten L, Goldbohm R, Van Den Brandt P. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study. Int J Gynecol Cancer 2006;16 Suppl 2:492.
13. Zendehdel K, Nyren O, Adami H, et al. Cancer incidence in patients with type 1 diabetes mellitus: a population - based cohort study in Sweden. J Natl Cancer Inst 2003;95:1797-1800.
14. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population - based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007;16:276-280.
15. Bratos K, Roszak A, Cikowska-Wońiak E, et al. Analiza czynników epidemiologicznych u chorych z rakiem błony śluzowej trzonu macicy leczonych w Wielkopolskim Centrum Onkologii. [Analysis of risk factors for endometrial neoplasia as a method for supplementation of indications for D&C in postmenopausal women with uterine bleeding]. Ginekol Pol 2002;76:945-950.
16. Dȩbska-Szmich S, Czernek U, Krakowska M, et al. Synchronous primary ovarian and endometrial cancers: a series of cases and a review of literature. Prz Menopauzalny 2014;1:64-69.
17. Rotsztejn H. The significance of fitoestrogens in the light of currant knowledge. Prz Menopauzalny 2005;4:47-50
18. Shannon JJ, Thomas D, Ray R, et al. Dietary risk factors for invasive and in situ cervical carcinomas in Bangkok, Thailand. Cancer Causes Control 2002;13:691-699.
19. McCullough ML, Bandera EV, Moore DF, Kushi LH. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev Med 2008;46:298-302.
20. Bravi F, Scotti L, Bosetti C, et al. Food groups and endometrial cancer risk: a case-control study from Italy. Am J Obstet Gynecol 2009;200:293.e1-293e7.
21. McTiernan A, Tworoger SS, Ulrich CM, et al. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. Cancer Res 2004;64:2923-2928.
22. Ainsworth BE, Haskell WL, Whitt MC, et al. Compedium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-S504.
23. Huddleston A, Zhen S, Qi L, et al. The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer. J Contemp Brachytherapy 2015;7:122-127.
24. Stucan M, Zalewski K, Brabowski JP, et al. Creation of the Polish version and adaptation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (QLQ-EN24). Contemp Oncol (Pozn) 2014;2:134-139.
25. Damast S, Higgins SA, Ratner E, et al. High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma. J Contemp Brachytherapy 2015;1:35-40.
26. Van Der Steen-Banasik E. Primary brachytherapy as a radical treatment for endometrial carcinoma. J Contemp Brachytherapy 2014;6:106-112.
27. Markowska J, Markowska A. Onkologia ginekologiczna. [Gynaecological Oncology]. Urban & Partner, Wroclaw 2002.
28. Wojciechowska U, Didkowska J, Zatoiski W. Nowotwory zioíliwe w Polsce w 2010 roku. [Cancer in Poland in 2010]. Centrum Onkologii. Instytut im. M. Skiodowskiej-Curie, Warszawa 2012.
29. Weiderpass E, Persson I, Adami HO, et al. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-192.
30. Calle EE, Rodriguez C, Walker-Thurmond K. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U. S. adults. N Engl J Med 2003;348:1625-1638.
31. Schouten L, Goldbohm R, Van Den Brandt P. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands cohort study. Int J Gynecol Cancer 2006;16 Suppl 2:492
32. Moszyiska-Zieliíska M, Cháubiśka-Fendler J, Gottwald L, et al. Does obesity hinder radiotherapy in endometrial cancer patients? The implementation of new techniques in adjuvant radiotherapy. focus on obese patients. Prz Menopauzalny 2014;13:96-100.
33. Zatośki W. Europejski kodeks walki z rakiem. [European Code Against Cancer]. Centrum Onkologii. Instytut im. Marii Skiodowskiej-Curie, Warszawa 2011.
34. Wojtyá-Buciora P, Stawiśka-Witoszyśka B, Klimberg A, et al. Nutritionrelated health behaviours and prevalence of overweight and obesity among Polish children and adolescents. Ann Agric Environ Med 2013;20:332-340.
35. Tian YF, Chu CH, Wu MH, et al. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer 2007;14:669-677.
36. Baloglu A, Bezircioglu I, Cetinkaya B, Hicyílmaz L. Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion in patients with endometrial adenocarcinoma. Ginekol Pol 2010;81:501-505.
37. Kancalska-Janssen O, Rajtar-Ciosek, Zmaczyśki A, et al. Markers of insulin resistance in perimenopausal women with endometrial pathology. Ginekol Pol 2013;84:922-929.
38. Markowska A, Pawaówska M, Lubin J, Markowska J. Signalling pathways in endometrial cancer. Contemp Oncol (Pozn) 2014;18:143-148.
39. Panasiuk L, Mierzecki A, Wdowiak L, et al. Prevalence of cigarette smoking among adult population in Eastern Poland. Ann Agric Environ Med 2010;17:133-138.
40. World Health Organisation Framework Convention on Tobacco Control 2003.
41. Fronczak A, Polaśka K, Dziankowska-Zaborszczyk E, et al. Changes in smoking prevalence and exposure to environmental tobacco smoke among adults iníodz, Poland. Ann Agric Environ Med 2012;4:754-761.
42. Parazzini F, La Vecchia C, Negri E, et al. Smoking and risk of endometrial cancer: results from an Italian case. control study. Gynecol Oncol 1995;23:55-62.
43. Zhou B, Yang L, Sun Q, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med 2008;121:501-508.
44. Tzonou A, Lipworth L, Kalandidil A. Dietary factors and the risk of endometrial cancer: a case. control study in Greece. Br J Cancer 1996;73:1284-1290.
45. Parazzini F, La Vecchia C, Bocciolone L, Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol 1991;41:1-16.
46. Bergier J. Studies and measurements of physical activity of the society. Ann Agric Environ Med 2012;3:329-331.
47. Pan SY, Johnson KC, Ugnat AM. Association of Obesity and Cancer Risk in Canada. Am J Epidemiol 2004;159:259-268.
48. Bandera EV, Kushi LH, Moore DF, et al. Consumption of animal foods and endomerial cancer risk: a systematic literature review and meta. analysis. Cancer Causes Control 2007;18:967-988.
49. Kushi LH, Byers T, Doyle C. American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2006;56:254-281.
50. Friedenreich CM, Cook LS, Magliocco AM, et al. Case-control study of lifetime total physical activity and endometrial cancer risk. Cancer Causes Control 2010;21:1105-1116.
51. Du M, Kraft P, Eliassen H, et al. Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health Study. Int J Cancer 2014;134:2707-2716.